Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 308 | 0 | 412 | 461 | 539 |
| Gross Profit | 308 | N/A | 412 | 461 | 539 |
| Operating Expenses | 3,096 | 3,099 | 3,827 | 5,622 | 6,155 |
| Operating Income | -2,788 | -4,511 | -3,415 | -5,161 | -5,616 |
| Other Income | 0 | 1,775 | 0 | 0 | 0 |
| Pre-tax Income | -2,788 | -2,737 | -3,415 | -5,161 | -5,616 |
| Net Income Continuous | -2,788 | -2,737 | -3,415 | -5,161 | -5,616 |
| Net Income | $-2,788 | $-2,737 | $-3,415 | $-5,161 | $-5,616 |
| EPS Basic Total Ops | -0.16 | -0.16 | -0.19 | -0.29 | -0.32 |
| EPS Basic Continuous Ops | -0.16 | -0.15 | -0.19 | -0.29 | -0.32 |
| EPS Diluted Total Ops | -0.16 | -0.16 | -0.19 | -0.29 | -0.32 |
| EPS Diluted Continuous Ops | -0.16 | -0.15 | -0.19 | -0.29 | -0.32 |
| EBITDA(a) | $-2,484 | $-2,793 | $-3,105 | $-4,818 | $-5,329 |